IRIS
PELAIA, GIROLAMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.651
AS - Asia 4.076
EU - Europa 1.635
SA - Sud America 1.135
AF - Africa 79
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 8
Totale 12.594
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.444
SG - Singapore 1.834
CN - Cina 924
BR - Brasile 877
IT - Italia 812
VN - Vietnam 497
IN - India 354
DE - Germania 190
GB - Regno Unito 167
HK - Hong Kong 162
SE - Svezia 143
CA - Canada 130
AR - Argentina 109
FI - Finlandia 72
BD - Bangladesh 65
EC - Ecuador 46
ID - Indonesia 45
MX - Messico 45
NL - Olanda 35
ES - Italia 29
IQ - Iraq 29
FR - Francia 28
RU - Federazione Russa 28
TR - Turchia 26
PY - Paraguay 23
VE - Venezuela 22
PL - Polonia 21
UA - Ucraina 21
JP - Giappone 19
ZA - Sudafrica 19
CL - Cile 17
PE - Perù 16
PK - Pakistan 16
CO - Colombia 14
MA - Marocco 14
CZ - Repubblica Ceca 13
DO - Repubblica Dominicana 13
EG - Egitto 13
IE - Irlanda 12
TW - Taiwan 12
UZ - Uzbekistan 11
SA - Arabia Saudita 10
AT - Austria 9
AU - Australia 9
IL - Israele 9
UY - Uruguay 9
LT - Lituania 8
RO - Romania 8
DZ - Algeria 7
KE - Kenya 7
LB - Libano 7
JO - Giordania 6
MY - Malesia 6
NP - Nepal 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
EU - Europa 5
IR - Iran 5
TT - Trinidad e Tobago 5
CH - Svizzera 4
CR - Costa Rica 4
DK - Danimarca 4
KZ - Kazakistan 4
PT - Portogallo 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
AZ - Azerbaigian 3
BN - Brunei Darussalam 3
HR - Croazia 3
HU - Ungheria 3
KG - Kirghizistan 3
LV - Lettonia 3
OM - Oman 3
PH - Filippine 3
PR - Porto Rico 3
AL - Albania 2
BG - Bulgaria 2
BH - Bahrain 2
BY - Bielorussia 2
EE - Estonia 2
GR - Grecia 2
HN - Honduras 2
KR - Corea 2
RS - Serbia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SV - El Salvador 2
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BO - Bolivia 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
ET - Etiopia 1
GH - Ghana 1
GY - Guiana 1
JM - Giamaica 1
KW - Kuwait 1
ML - Mali 1
Totale 12.585
Salva come PNG Salva come JPEG
Città #
San Jose 1.151
Singapore 601
Chandler 574
Ashburn 498
Dallas 368
Santa Clara 325
Bengaluru 288
Hefei 288
Milan 249
Lawrence 227
Princeton 227
Ho Chi Minh City 199
Hong Kong 157
Beijing 147
Wilmington 144
Chicago 119
Munich 117
London 116
Hanoi 98
Ottawa 91
São Paulo 82
Catanzaro 73
Des Moines 71
Turku 51
Boardman 49
New York 41
Los Angeles 40
Naples 34
Rome 33
Shanghai 30
Da Nang 26
Rio de Janeiro 26
Quito 22
San Francisco 22
Haiphong 21
Mexico City 21
Palermo 21
Warsaw 21
Atlanta 19
Guangzhou 19
Redwood City 19
Brooklyn 18
Helsinki 18
Norwalk 18
Seattle 18
The Dalles 18
Florence 17
Hanover 17
Biên Hòa 16
Buenos Aires 16
San Nicola Manfredi 16
Belo Horizonte 15
Boston 15
Council Bluffs 15
Redmond 15
Troina 15
Baghdad 14
Orem 14
Phoenix 14
Curitiba 13
Lima 13
Olomouc 13
Salvador 13
Thái Bình 13
Tokyo 13
Columbus 12
Dhaka 12
Guayaquil 12
Ankara 11
Hải Dương 11
Ninh Bình 11
Shenzhen 11
Tashkent 11
Dublin 10
Paris 10
Amsterdam 9
Asunción 9
Bologna 9
Campinas 9
Chennai 9
Pune 9
Brasília 8
Cairo 8
Guarulhos 8
Johannesburg 8
New Delhi 8
Osasco 8
Porto Alegre 8
Santo Domingo 8
Taipei 8
Toronto 8
Wuhan 8
Augusta 7
Bauru 7
Cape Town 7
Falls Church 7
Frankfurt am Main 7
Goiânia 7
Istanbul 7
Manchester 7
Totale 7.401
Salva come PNG Salva come JPEG
Nome #
Ascaris lumbricoides-induced suppression of total and specific IgE responses in atopic subjects is interleukin 10-independent and associated with an increase of CD25(+) cells 132
Arg16Gly 132-Adrenoreceptor Polymorphism in Severe Eosinophilic Asthma: Implications for Mepolizumab Long-Term Effectiveness and Clinical Remission 98
An Analytical Method for Assessing Optimal Storage Conditions of Gingival Crevicular Fluid and Disclosing a Peptide Biomarker Signature of Gingivitis by MALDI-TOF MS 98
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study 91
Ruolo dei calcio-antagonisti nella prevenzione e nel trattamento dell’asma bronchiale 91
Effects of budesonide on p38 MAPK activation, apoptosis and IL-8 secretion, induced by TNF-α and Haemophilus influenzae in human bronchial epithelial cells 88
High-flow nasal oxygen therapy in intensive care and anaesthesia 85
Application of proteomics and peptidomics to COPD 82
Endothelin-1 induces proliferation of human lung fibroblasts and IL-11 secretion through an ET(A) receptor-dependent activation of MAP kinases 82
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 81
High-flow nasal cannula oxygen therapy for outpatients undergoing flexible bronchoscopy: a randomised controlled trial 81
Biological mechanisms underlying the clinical effects of allergen-specific immunotherapy in asthmatic children 77
A case of Hughes-Stovin sindrome associated with Budd-Chiari sindrome 76
Effects of the first three doses of benralizumab on symptom control, lung function, blood eosinophils, oral corticosteroid intake, and nasal polyps in a patient with severe allergic asthma 75
Adverse drug reactions to antibiotics observed in two pulmonology divisions of Catanzaro, Italy: A six-year retrospective study 73
Rapid detection and identification of antimicrobial peptide fingerprints of nasal fluid by mesoporous silica particles and MALDI-TOF/TOF mass spectrometry: from the analytical approach to the diagnostic applicability in precision medicine 73
Type 2 severe asthma: pathophysiology and treatment with biologics 71
Covid-19 and the role of smoking: The protocol of the multicentric prospective study COSMO-IT (covid19 and smoking in italy) 71
Clinical and Functional Effects of Inhaled Dual Therapy Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease: A Real-Life Study 70
New treatments for asthma: From the pathogenic role of prostaglandin D2 to the therapeutic effects of fevipiprant 70
Asthma and COPD proteomics: Current approaches and future directions 69
Alpha-interferon and its effects on signal transduction pathways 68
A single-blind comparative study of the effects of inhaled fluticasone propionate and nedocromil sodium on airway hyperresponsiveness to methacholine 68
A rapid differential display analysis of nasal swab fingerprints to distinguish allergic from non-allergic rhinitis subjects by mesoporous silica particles and MALDI-TOF mass spectrometry 68
Peptidomic analysis of induced sputum of asthmatic patients by MSB-MALDI-TOF-MS platform 68
A case of Hughes-Stovin syndrome associated with Budd-Chiari syndrome 68
Interleukin-6 receptor superantagonist Sant7 inhibits TGF-beta-induced proliferation of human lung fibroblasts 68
Benralizumab in the treatment of severe asthma: design, development and potential place in therapy 67
A single-blind, partial crossover clinical trial of the effects of inhaled fluticasone propionate and nedocromil sodium on airway hyperresponsiveness to methacholine 67
Is the mitochondrial benzodiazepine receptor involved in the control of airway smooth muscle tone? 65
A case of alveolar proteinosis associated with pulmonary nocardiosis 65
The sodium-phosphate co-transporter SLC34A2, and pulmonary alveolar microlithiasis: presentation of an inbred family and a novel truncating mutation in exon 3 65
Theophylline action on primary human bronchial epithelial cells under proinflammatory stimuli and steroidal drugs: a therapeutic rationale approach 65
Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseases 64
An integrated metabo-lipidomics profile of induced sputum for the identification of novel biomarkers in the differential diagnosis of asthma and COPD 63
Asthma management in a specialist setting: results of an Italian Respiratory Society survey 63
Objective and self-evaluation voice analysis after transoral laser cordectomy and radiotherapy in T1a-T1b glottic cancer 63
Effects of Ambrisentan in a Patient Affected by Combined Pulmonary Fibrosis and Emphysema and by Severe Pulmonary Hypertension: Clinical, Functional, and Biomolecular Findings 61
Anti-IgE therapy with omalizumab for severe asthma: current concepts and potential developments 61
Influence of storage conditions on MALDI-TOF MS profiling of gingival crevicular fluid: Implications on the role of S100A8 and S100A9 for clinical and proteomic based diagnostic investigations 61
Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug dose 61
Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence 61
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study 60
Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non small lung cancer cells. 60
Application of MSB-MALDI-TOF-MS Technology to body fluids and Tissues peptidome profiling 60
LEBRIKIZUMAB Anti-interleukin-13 monoclonal antibody, Treatment of asthma 60
A rapid differential display analysis of nasal swab fingerprints to distinguish allergic from non-allergic rhinitis subjects by mesoporous silica particles and MALDI-TOF mass spectrometry 60
Airways smooth muscle response to biological stimuli 59
A rare case of infection of the lower respiratory tract caused by Bordetella bronchiseptica 59
Molecular mechanisms underlying airway smooth muscle contraction and proliferation: Implications for asthma 59
Adverse drug reactions in hospitalized patients following antibiotics administration 58
Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets 57
Benralizumab:from the basic mechanism of action to the potential use in the biological therapy of severe eosinophilic asthma 57
Kartagener's syndrome in a woman with a normal ciliary structure and an intracranial meningioma 57
Anticolinergici 57
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super-Response and Remission With Mepolizumab 56
Valutazione in doppio cieco dell’effetto broncodilatante del procaterolo somministrato per aerosol dosato 56
Emerging biological treatments for asthma 55
Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxide 55
Adverse drug reactions in hospitalized patients following bronchodilators administration 54
Adverse drug reactions in hospitalized patients following NSAIDs administration 54
Adverse drug reaction in two pneumology units of Catanzaro 54
Effects of MAPK inhibitors on H2O2-induced IL-8 production and cell death in primary cultures of human bronchial epithelial cells 54
Use of narrative medicine to identify key factors for effective doctor-patient relationships in severe asthma 54
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial 54
Real-Life Clinical and Functional Effects of Fluticasone Furoate/Umeclidinium/Vilanterol-Combined Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease 54
Persistence of both reversible airway obstruction and higher blood eosinophils may predict lung function decline in severe asthma 54
Neuron-specific enolase serum levels in COVID-19 are related to the severity of lung injury 54
Role of biologics in severe eosinophilic asthma - focus on reslizumab 53
Early management of COPD: where are we now and where do we go from here? 53
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study 53
Oxygenation strategies during flexible bronchoscopy: a review of the literature 53
Agonisti beta2-adrenergici 52
Effects of simvastatin and rosuvastatin on RAS protein, matrix metalloproteinases and NF-kappa B in lung cancer and in normal pulmonary tissues 52
Effects of glucocorticoids on activation of c-jun N-terminal, extracellular signal-regulated, and p38 MAP kinases in human pulmonary endothelial cells 51
Nitric oxide in upper airways inflammatory diseases 51
Ascaris lumbricoides-induced suppression of total and specific IgE responses in atopic subjects is interleukin 10-indipendent and associated with an increase of CD25+ cells 51
Inhibitory effects of the IL-6 receptor superantagonist SANT7 on MAP kinase phosphorylation and cell proliferation induced by IL-6 and TGF-beta1in human lung fibroblasts 51
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy 51
Effects of transforming growth factor-β and budesonide on mitogen-activated protein kinase activation and apoptosis in airway epithelial cells 51
Real-world experience with benralizumab in patients with severe eosinophilic asthma: A case series 51
Predictors of renal function worsening in patients with chronic obstructive pulmonary disease (Copd): A multicenter observational study 51
Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma 51
STRUCTURE OF THE RAT GENE ENCODING THE MITOCHONDRIAL BENZODIAZEPINE RECEPTOR 50
P38 signalling pathway in primary cultures of human bronchial epithelial cells: effects of transforming growth factor-β and pharmacological modulation by budesonide 50
T CELL ACTIVATION STATE IN THE INDUCED SPUTUM OF ASTHMATICS TREATED WITH BUDESONIDE 50
Basi fisiopatologiche della terapia del broncospasmo 50
Clinical relevance of understanding mitogen-activated protein kinases involved in asthma 50
Phenotyping severe asthma: a rationale for biologic therapy 50
Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence. 50
Real-Life Effects of Omalizumab on Chronic Rhinosinusitis with Nasal Polyposis 49
The severe asthma network in Italy: findings and perspectives 49
Molecular mechanisms of corticosteroid actions in chronic inflammatory airway diseases 49
Shadow cost of oral corticosteroids-related adverse events: a pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry. 49
Effects of transforming growth factor-beta and budesonide on mitogen-activated protein kinase activation and apoptosis in airway epithelial cells 49
Switching from omalizumab to mepolizumab: real-life experience from Southern Italy 49
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness 48
Effects of non-bronchoconstrictive doses of inhaled propranolol on airway responsiveness to methacholine 48
Effect of inhaled heparin on water-induced bronchoconstriction in allergic asthmatics 48
An insight into pharmacological and clinical basis of anti-IgE for add-on therapy of severe asthma 48
Totale 6.176
Salva come PNG Salva come JPEG
Categoria #
all - tutte 125.504
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 125.504
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 0 0 0 0 0 7
2021/2022584 4 5 19 111 46 18 31 141 53 57 89 10
2022/20231.692 465 65 66 127 182 169 16 116 276 78 110 22
2023/2024686 143 90 59 37 36 169 14 24 8 27 24 55
2024/20252.718 412 137 97 105 194 344 93 75 348 144 280 489
2025/20266.712 325 754 762 1.269 643 274 806 369 857 413 173 67
Totale 12.851